Ignite Creation Date:
2024-05-05 @ 4:49 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00326976
Status:
COMPLETED
Last Update Posted:
2007-12-04
First Post:
2006-05-16
Brief Title:
Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury
Sponsor:
Fibrex Medical Research Development GmbH
Organization:
Fibrex Medical Research Development GmbH
Study Overview
Official Title:
A Multicenter Double Blind Randomized Placebo Controlled Study to Measure the Effect of FX06 a Fibrin Derived Peptide Bbeta15-42 on Ischemia Reperfusion Injury in Patients Undergoing Primary Percutaneous Coronary Intervention PCI The FIRE Study
Status:
COMPLETED
Status Verified Date:
2007-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to evaluate whether FX06 is capable of limiting infarct size following balloon catheterization for acute myocardial infarction
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None